3 Reasons to attend online:

1. Understand how to take advantage of registries & external data to develop RWE that can best provide value to KOLs, payers & regulators

2. Benchmark how technologies like AI, Big Data, Cloud, EDC, PROs or EHR can maximise the potential, evidence & insights from real-world registries

3. Learn how industry leaders are collaborating with KOLs, payers & stakeholders to generate robust, quality evidence 

Speakers List

INDUSTRY EXPERTS

Chief Medical Officer & Head of Global Medical Affairs
Eisai

Vice President, Health Economics and Outcomes Research, Global Oncology 
Abbvie 

Head of Real World Evidence, Oncology Business Unit, Medical Affairs
AstraZeneca 

Head of Real-World Evidence, EMEA
Janssen, Pharmaceutical Companies of Johnson and Johnson

Executive Medical Director Western Europe, Middle East & Africa 
Amgen

Global Vice President, Medical Affairs, Chief Medical Officer
Bioventus

Senior Adviser, Manager of Research and Development
The Norwegian Association for Pharma Industry (Legemiddelindustrien)

Director, Government Affairs, Policy & Health Economics
GE Healthcare

EXTERNAL STAKEHOLDERS

Professor of Clinical Oncology, CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories
University of Oxford

Chair of the EUBIROD Network 
President of the HUB for International health research-HIRS

Former Alternate Patient member of the
EMA Committee on Advanced Therapies (CAT)
Patient Advocate

RWE & TECHNOLOGY EXPERTS

Development Director Real-World Evidence
OPEN Health

Global Business Development Director - Head of Real World Evidence
Carenity - EvidentIQ Group

 

Founder & Chief Medical Officer 
Savana 

CEO and Co-founder 
Quertle

Business Development Manager
Karger

Regional Manager
Karger

Customer Engineer, Healthcare and Life sciences
Google Cloud

Customer Engineer, Healthcare and Life sciences
Google Cloud

Event Structure

Event Overview

STRATEGY AND PARTNERSHIPS

Day 1 - 20th April, 2021

UTILIZING REGISTRIES BEST PRACTICES

Day 2 - 21st April, 2021

EVENT PARTNER

Related Videos

Presentation

Measuring the return from pharmaceutical innovation 2018

Related topics: Discovery & R&D Innovation, Digital & Technology
Availability: FREE

The biopharma industry continues to face challenges this year, with projected returns on investment in R&D at the lowest levels since our analysis began in 2010. However, there are opportunities to reverse this trend, which will require new ways of working and a complete digital transformation to unlock R&D productivity and deliver the next generation of scientific breakthroughs.

Speaker

Mark Steedman
Research Manager
Deloitte UK Centre for Health Solutions

Presentation

Extreme-Scale Cloud-Based Infrastructure needed for global genomic data

Related topics: IT & Big Data
Availability: FREE
  • Cloud genomic data sets are approaching a total of 250 Petabytes representing an unprecedented resource for research and clinical applications
  • Extreme-scale cloud-based compute and tools are required to federate and utilize the emerging global resource, conforming to localized compliance requirements
  • A rapid evolution in data resource architecture and applicable tools is required, with an important role to be played by Artificial Intelligence
Speaker

Richard Daly
CEO
DNAnexus, Inc., USA

View Agenda or Register